These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 4647388)

  • 1. The effect of oral urea administration on red cell survival in sickle cell disease.
    Bensinger TA; Mahmood L; Conrad ME; McCurdy PR
    Am J Med Sci; 1972 Oct; 264(4):283-7. PubMed ID: 4647388
    [No Abstract]   [Full Text] [Related]  

  • 2. Oral urea therapy in sickle-cell anemia. A preliminary report.
    Lipp EC; Rudders RA; Pisciotta AV
    Ann Intern Med; 1972 May; 76(5):765-8. PubMed ID: 5025327
    [No Abstract]   [Full Text] [Related]  

  • 3. Sickle cell crisis terminated by intravenous urea in sugar solutions--a preliminary report.
    Nalbandian RM; Shultz G; Lusher JM; Anderson JW; Henry RL
    Am J Med Sci; 1971 Jun; 261(6):309-24. PubMed ID: 5149896
    [No Abstract]   [Full Text] [Related]  

  • 4. Anaemia in renal disease.
    Pryor JS; Joekes AM
    Br J Urol; 1969 Aug; ():Suppl:88-96. PubMed ID: 5810520
    [No Abstract]   [Full Text] [Related]  

  • 5. Oral urea and the prophylactic treatment of sickle cell disease--a preliminary report.
    Nalbandian RM; Anderson JW; Lusher JM; Agustsson A; Henry RL
    Am J Med Sci; 1971 Jun; 261(6):325-34. PubMed ID: 5149897
    [No Abstract]   [Full Text] [Related]  

  • 6. Intravenous urea treatment of the painful crisis of sickle-cell disease. A preliminary report.
    McCurdy PR; Mahmood L
    N Engl J Med; 1971 Oct; 285(18):992-4. PubMed ID: 5094819
    [No Abstract]   [Full Text] [Related]  

  • 7. Evaluation of oral urea in the management of sickle cell anemia.
    Lusher JM; Barnhart MI
    Adv Exp Med Biol; 1972; 28():303-21. PubMed ID: 5085174
    [No Abstract]   [Full Text] [Related]  

  • 8. [Therapeutic evaluation of oral urea in a case of sickle cell anemia].
    Muranda M; Etcheverry R; Becker P; Duran N; Saavedra L; Pemjean I
    Rev Med Chil; 1972 Apr; 100(4):426-9. PubMed ID: 5041766
    [No Abstract]   [Full Text] [Related]  

  • 9. Urea therapy in sickle cell disease: a report of 38 treated cases.
    Scrimgeour A
    East Afr Med J; 1973 Dec; 50(12):681-95. PubMed ID: 4786005
    [No Abstract]   [Full Text] [Related]  

  • 10. Urea and sickling.
    Eyre JT; Ashcom RC; Black AV; Desforges JF; Smith R; Sugerman H; Lubin B; Oski F
    N Engl J Med; 1971 Jul; 285(5):295-6. PubMed ID: 5090406
    [No Abstract]   [Full Text] [Related]  

  • 11. The haematological response to androgens in sickle cell anaemia.
    Lundh B; Gardner FH
    Scand J Haematol; 1970; 7(5):389-97. PubMed ID: 5486781
    [No Abstract]   [Full Text] [Related]  

  • 12. Red cell lifespan in hemoglobin C disorders (with special reference to hemoglobin C trait).
    Prindle KH; McCurdy PR
    Blood; 1970 Jul; 36(1):14-9. PubMed ID: 5421740
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of intravenous urea in invert sugar on heme catabolism in sickle-cell anemia.
    Bensinger TA; Maisels MJ; Mahmood L; McCurdy PR; Conrad ME
    N Engl J Med; 1971 Oct; 285(18):995-7. PubMed ID: 5094820
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of sickle cell crisis with urea in invert sugar. A controlled trial. Cooperative urea trials group.
    JAMA; 1974 May; 228(9):1125-8. PubMed ID: 4596707
    [No Abstract]   [Full Text] [Related]  

  • 15. Oral urea therapy in children with sickle cell anemia.
    Lubin BH; Oski FA
    J Pediatr; 1973 Feb; 82(2):311-3. PubMed ID: 4684378
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of sickle-cell crises.
    Brody JI
    N Engl J Med; 1972 Sep; 287(12):616. PubMed ID: 5055217
    [No Abstract]   [Full Text] [Related]  

  • 17. Oral urea in sickle-cell disease.
    Nalbandian RM
    Ann Intern Med; 1972 Oct; 77(4):659-60. PubMed ID: 4642751
    [No Abstract]   [Full Text] [Related]  

  • 18. [Use of intravenous urea in the treatment of the patinful crises of sickle cell anemia].
    Hernández P; Castro R; Portuondo H; Ferrá M; Méndez J; Boffill V; Bopha K; Lagarde M
    Rev Invest Clin; 1972; 24(1):83-9. PubMed ID: 5032344
    [No Abstract]   [Full Text] [Related]  

  • 19. Improvements in haemolysis and indicators of erythrocyte survival do not correlate with acute vaso-occlusive crises in patients with sickle cell disease: a phase III randomized, placebo-controlled, double-blind study of the Gardos channel blocker senicapoc (ICA-17043).
    Ataga KI; Reid M; Ballas SK; Yasin Z; Bigelow C; James LS; Smith WR; Galacteros F; Kutlar A; Hull JH; Stocker JW;
    Br J Haematol; 2011 Apr; 153(1):92-104. PubMed ID: 21323872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urea treatment of sickle-cell crisis.
    Nalbandian RM
    N Engl J Med; 1971 Aug; 285(7):408. PubMed ID: 5556583
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.